+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticancer Agent"

Medical Foods Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030 - Product Thumbnail Image

Medical Foods Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

  • Report
  • November 2022
  • 115 Pages
  • Global
From
Cell Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Cell Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 115 Pages
  • Global
From
Health Economics and Outcomes Research (HEOR) Services Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Health Economics and Outcomes Research (HEOR) Services Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • June 2022
  • 115 Pages
  • Global
From
Research Report on China's Anlotinib Hydrochloride Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Anlotinib Hydrochloride Market, 2021-2025

  • Report
  • November 2021
  • 40 Pages
  • China
From
Research Report on China's Lobaplatin Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Lobaplatin Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Investigation Report on China's Osimertinib Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Osimertinib Market 2021-2025

  • Report
  • April 2021
  • China
From
Europe Antibody Drug Conjugates Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Europe Antibody Drug Conjugates Market - Forecasts from 2022 to 2027

  • Report
  • May 2022
  • 84 Pages
  • Europe
From
North America Antibody Drug Conjugates Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

North America Antibody Drug Conjugates Market - Forecasts from 2022 to 2027

  • Report
  • April 2022
  • 95 Pages
  • North America
From
The Global Antibody-Drug Conjugates Market - Forecasts from 2019 to 2024 - Product Thumbnail Image

The Global Antibody-Drug Conjugates Market - Forecasts from 2019 to 2024

  • Report
  • September 2019
  • 98 Pages
  • Global
From
Global Oncology Drugs Market 2018-2024 - Product Thumbnail Image

Global Oncology Drugs Market 2018-2024

  • Report
  • March 2018
  • 102 Pages
  • Global
From
Revlimid - Product Thumbnail Image

Revlimid

  • Report
  • January 2019
  • 56 Pages
  • Global
From
Nanopharmaceuticals - Thematic Research - Product Thumbnail Image

Nanopharmaceuticals - Thematic Research

  • Report
  • March 2020
  • 96 Pages
  • Global
From
Asia Pacific Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application, By Technology, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Asia Pacific Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application, By Technology, By Country and Growth Forecast, 2022 - 2028

  • Report
  • May 2022
  • 93 Pages
  • Asia Pacific
From
LAMEA Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application, By Technology, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

LAMEA Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application, By Technology, By Country and Growth Forecast, 2022 - 2028

  • Report
  • May 2022
  • 91 Pages
  • Middle East, Africa
From
North America Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application, By Technology, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

North America Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application, By Technology, By Country and Growth Forecast, 2022 - 2028

  • Report
  • May 2022
  • 84 Pages
  • North America
From
Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H1 2019 - Product Thumbnail Image

Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H1 2019

  • Drug Pipelines
  • March 2019
  • 62 Pages
  • Global
From
Pharmaceuticals Industry Forecasts - China Focus - Product Thumbnail Image

Pharmaceuticals Industry Forecasts - China Focus

  • Report
  • February 2024
  • 106 Pages
  • China
From
Anti-Tumor Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Anti-Tumor Drugs Industry Forecasts - China Focus

  • Report
  • November 2023
  • 107 Pages
  • China
From
Prescription Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Prescription Drugs Industry Forecasts - China Focus

  • Report
  • October 2023
  • 93 Pages
  • China
From
Prescription Drugs Markets in China - Product Thumbnail Image

Prescription Drugs Markets in China

  • Report
  • October 2023
  • 217 Pages
  • China
From
Loading Indicator

The Anticancer Agent market is a segment of the Healthcare Services industry that focuses on the development and distribution of drugs and treatments for cancer. These agents are designed to target and destroy cancer cells while minimizing the damage to healthy cells. They can be administered orally, intravenously, or topically, depending on the type of cancer and the patient's individual needs. Anticancer agents are used in combination with other treatments such as radiation and chemotherapy to provide the best possible outcome for the patient. The Anticancer Agent market is highly competitive, with many companies vying for market share. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more